Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-22T17:43:08.926Z Has data issue: false hasContentIssue false
  • English
  • Français

The Marketing of 5-Hydroxytryptamine: Depression or Anxiety?

Published online by Cambridge University Press:  02 January 2018

David Healy
David Healy*
Affiliation:
Academic Sub-Department of Psychological Medicine, North Wales Hospital, Denbigh, Clwyd LL16 5SS
Get access Rights & Permissions [Opens in a new window]

Extract

The discovery that tricyclic antidepressants blocked the re-uptake of both noradrenaline and 5-hydroxytryptamine (5-HT) was a significant step on the road to the development of the monoamine hypotheses of depression (Healy, 1987). The subsequent demonstration that the de-aminated metabolites of amitriptyline and imipramine, nortriptyline and desipramine, were antidepressants tilted the balance toward noradrenaline as the pertinent neurotransmitter, as these latter drugs were clearly inhibitors of noradrenergic rather than 5-HT uptake.

Type
Annotation
Information
The British Journal of Psychiatry , Volume 158 , Issue 6 , June 1991 , pp. 737 - 742
Copyright
Copyright © The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Barker, W. A., Scott, J. S. & Eccleston, D. (1987) The Newcastle chronic depression study: results of a treatment regime. International Clinical Psychopharmacology, 2, 261–272.Google Scholar
Barrow, N. & Childs, A. (1986) Anti-tardive dyskinesia effect of verapamil. American Journal of Psychiatry, 143, 1485.Google Scholar
Carlsson, A. (1990) Early psychopharmacology and the rise of modern brain research. Journal of Psychopharmacology, 4, 120–126.Google Scholar
Cordoba, E. E. & Lopez-Ibor, J. J. (1967) Monochlorimipramine in psychiatric patients resistant to other forms of treatment. Actas Luso-Espanolas de Neurologia, Psyquiatrica y ciencas Afines, 26, 119–147.Google Scholar
Costall, B., Naylor, R. J. & Tyers, M. B. (1988) Recent advances in the neuropharmacology of 5HT-3 agonists and antagonists. Reviews in the Neurosciences, 2, 41–65.Google Scholar
Costall, B., Naylor, R. J. & Tyers, M. B. (1990) The psychopharmacology of 5HT receptors. Pharmacology and Therapeutics, 47, 181–202.Google Scholar
Cowen, P. J., Geaney, D. P., Schachter, M., et al (1986) Desmethylimipramine treatment in normal subjects: effects on neuroendocrine responses to L-tryptophan and platelet 5HT-related receptors. Archives of General Psychiatry, 43, 61–67.Google Scholar
Davis, M. (1987) Mescaline: excitatory effects on acoustic startle are blocked by serotonin-2 antagonists. Psychopharmacology, 93, 286–291.CrossRefGoogle Scholar
De Montiony, C., Grunberg, F., Mayer, A., et al (1981) Lithium induces rapid relief of depression in tricyclic antidepressant drug nonresponders. British Journal of Psychiatry, 138, 252–256.Google Scholar
De Montiony, C., Chaput, Y. & Blier, P. (1988) Lithium augmentation of antidepressant treatments: evidence for an involvement of the 5HT system. In New Concepts in Depression (eds M. Briley & G. Fillion), pp. 144–160. Basingstoke: Macmillan Press.Google Scholar
Fattacini, C. M., Bolanos-Jimenez, F., Gozlan, H., et al (1990) Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain. Neuropharmacology, 29, 1–8.Google Scholar
Ferrer, I. N., Eccleston, D., Moore, P. B., et al (1990) Relapse in chronic depressives on withdrawal of L-tryptophan. Lancet, 336, 380–381.CrossRefGoogle Scholar
Gelders, Y. G. (1989) Thymosthenic agents, a novel approach to the treatment of schizophrenia. British Journal of Psychiatry, 155 (suppl. 5), 33–36.CrossRefGoogle Scholar
Glennon, R. A. (1990) Serotonin receptors: Clinical implications. Neuroscience and Biobehavioural Reviews, 14, 35–47.Google Scholar
Gonzalbz-Heydrich, J. & Peroutka, S. J. (1990) Serotonin receptor and reuptake sites: pharmacologic significance. Journal of Clinical Psychiatry, 51 (suppl. 4), 5–12.Google Scholar
Hale, A. S., Proctor, A. W. & Bridges, P. K. (1987) Clomipramine, tryptophan and lithium in combination for resistant endogenous depression: seven case studies. British Journal of Psychiatry, 151, 213–217.Google Scholar
Healy, D. (1987) The structure of psychopharmacological revolutions. Psychiatric Developments, 5, 349–376.Google Scholar
Healy, D. (1989) Neuroleptics and psychic indifference. Journal of the Royal Society of Medicine, 82, 615–619.Google Scholar
Healy, D. (1990) The psychopharmacological era: Notes toward a history. Journal of Psychopharmacology, 4, 152–167.Google Scholar
Healy, D., O'Halloran, A., Carney, P. A., et al (1985) Peripheral adrenoceptors and serotonin receptors: changes associated with response to treatment with trazodone or amitriptyline. Journal of Affective Disorders, 9, 285–296.CrossRefGoogle ScholarPubMed
Heninoer, G. R., Charney, D. S. & Sternberg, D. E. (1983) Lithium carbonate augmentation of antidepressant treatment. Archives of General Psychiatry, 40, 1335–1342.Google Scholar
Jones, B. J., Costall, B., Domeney, A. M., et al (1988) The potential anxiolytic activity of GR38032F, a 5HT-3 receptor antagonist. British Journal of Pharmacology, 93, 985–993.CrossRefGoogle Scholar
Kazdin, A. E. (1982) Single Case Designs. New York: Oxford University Press.Google Scholar
Kravitz, H. M., Fogg, L., Fawcett, J., et al (1990) Antidepressant or antianxiety? A study of the efficacy of antidepressant medication. Psychiatric Research, 32, 141–149.Google Scholar
Kuhn, R. (1990) Artistic imagination and the discovery of antidepressants. Journal of Psychopharmacology, 4, 127–130.Google Scholar
Leonard, B. E. (1988) Biochemical aspects of therapy resistant depression. British Journal of Psychiatry, 152, 453–458.CrossRefGoogle ScholarPubMed
Lingjaerde, O., Edlund, A. H., Gormsen, C. A., et al (1974) The effect of lithium carbonate in combination with tricyclic antidepressants in endogenous depression. Acta Psychiatrica Scandinavica, 50, 233–242.CrossRefGoogle ScholarPubMed
Lipinski, J. F., Mallaya, G., Zimmerman, P., et al (1989) Fluoxetine-induced akathisia: Clinical and theoretical implications. Journal of Clinical Psychiatry, 50, 339–342.Google ScholarPubMed
Marks, I. M., Lelliott, P., Basoglu, M., et al (1988) Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals. British Journal of Psychiatry, 152, 522–534.Google Scholar
Peroutka, S. J. (1988) 5-Hydroxytryptamine receptor subtypes. Annual Review of Neuroscience, 11, 45–60.Google Scholar
Peroutka, S. J. & Snyder, S. H. (1979) Multiple serotonin receptors: Differential binding of 3H.5-hydroxytryptamine, 3H.lysergic acid diethylamide and 3H.spiroperidol. Molecular Pharmacology, 16, 687–699.Google Scholar
Pinder, R. (1987) The benefits and risks of antidepressant drugs. Human Psychopharmacology, 3, 73–86.CrossRefGoogle Scholar
Price, L. H. (1989) Lithium augmentation of tricyclic antidepressants. In Treatment of Tricyclic Resistant Depression (ed. I. Extein). Washington, DC: American Psychiatric Press.Google Scholar
Price, L. H., Charney, D. S., Delgado, P. L., et al (1990) Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacology, 100, 3–12.CrossRefGoogle ScholarPubMed
Quitkin, F. M., Rabkin, J. G., Ross, D., et al (1984) Identification of true drug response to antidepressants. Archives of General Psychiatry, 41, 782–786.Google Scholar
Rickels, K., Feighner, J. P. & Smith, W. T. (1985) Alprazolam, amitriptyline, doxepin and placebo in the treatment of depression. Archives of General Psychiatry, 42, 134–141.CrossRefGoogle ScholarPubMed
Robertson, M. M. & Trimble, M. R. (1982) Major tranquillisers used as antidepressants. Journal of Affective Disorders, 4, 173–193.CrossRefGoogle ScholarPubMed
Sandler, M. (1990) Monoamine oxidase inhibitors in depression: history and mythology. Journal of Psychopharmacology, 4, 136–139.Google Scholar
Shapira, B., Kindler, S. & Lerer, B. (1988) Medication outcome in treatment resistant depression. Convulsive Therapy, 4, 192–198.Google Scholar
Sneader, W. (1990) The prehistory of psychotherapeutic agents. Journal of Psychopharmacology, 4, 115–119.Google Scholar
Sulser, F. (1984) Regulation and function of noradrenaline receptor systems in brain. Neuropharmacology, 23, 255–261.Google Scholar
Tiller, J., Schweitzer, I., Maguire, K., et al (1989) Is diazepam an antidepressant? British Journal of Psychiatry, 155, 483–489.Google Scholar
Tricklebank, M. D. (1989) Interactions between dopamine and 5HT-3 receptors suggest new treatments for psychosis and drug addiction. Trends in Pharmacological Sciences, 10, 127–129.Google Scholar
Zohar, J., Insel, T. R., Zohar-Kadouch, R. C., et al (1988) Serotonergic responsivity in obsessive–compulsive disorder. Effects of chronic clomipramine treatment. Archives of General Psychiatry, 45, 167–172.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.